US Stock MarketDetailed Quotes

CLRB Cellectar BioSciences

Watchlist
  • 3.0900
  • +0.0500+1.64%
Close May 31 16:00 ET
  • 3.0800
  • -0.0100-0.32%
Post 18:54 ET
110.77MMarket Cap-1000P/E (TTM)

Cellectar BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-86.00%-13.36M
-28.37%-32.38M
-29.47%-9.6M
-15.04%-8.07M
-30.78%-7.53M
-42.54%-7.18M
-11.76%-25.22M
-64.30%-7.41M
-9.09%-7.01M
16.27%-5.76M
Net income from continuing operations
-151.50%-21.58M
-32.80%-37.98M
-3.24%-7.45M
-75.80%-13.73M
-10.57%-8.22M
-39.76%-8.58M
-18.57%-28.6M
-21.92%-7.22M
-34.24%-7.81M
-23.34%-7.44M
Operating gains losses
--9.9M
-15,752.69%-530K
---4.9M
----
----
----
15.29%3.39K
--0
--0
----
Depreciation and amortization
107.93%88.49K
29.60%192.38K
83.34%69.96K
25.02%41.21K
14.02%38.65K
-1.98%42.56K
-0.99%148.44K
-2.88%38.16K
-10.41%32.96K
-12.42%33.9K
Other non cash items
11.62%15.44K
-35.81%58.05K
-36.01%15.28K
-35.98%14.73K
-35.94%14.21K
-35.25%13.83K
16.35%90.43K
16.17%23.89K
16.30%23.01K
16.40%22.18K
Change In working capital
-339.90%-2.24M
106.43%3.48M
355.30%1.58M
97.82%740.65K
-81.73%218.89K
27.56%933.01K
747.12%1.68M
-163.97%-620.16K
134.42%374.41K
208.27%1.2M
-Change in prepaid assets
8.14%-448.96K
-184.97%-173.55K
-24.77%235.24K
-34.36%-666.79K
165.97%746.72K
-556.47%-488.72K
319.49%204.24K
73.14%312.69K
29.21%-496.27K
-34.38%280.75K
-Change in payables and accrued expense
-225.14%-1.78M
127.91%3.7M
253.51%1.36M
57.27%1.42M
-153.96%-512.87K
117.13%1.43M
294.33%1.62M
-208.31%-888.59K
353.77%904.77K
163.16%950.55K
-Change in other current liabilities
-5.96%-4.64K
64.70%-50.85K
63.78%-16.03K
54.58%-15.48K
55.03%-14.95K
86.50%-4.38K
-20.13%-144.04K
-39.92%-44.26K
-13.03%-34.09K
-13.03%-33.25K
Cash from discontinued investing activities
Operating cash flow
-86.00%-13.36M
-28.37%-32.38M
-29.47%-9.6M
-15.04%-8.07M
-30.78%-7.53M
-42.54%-7.18M
-11.76%-25.22M
-64.30%-7.41M
-9.09%-7.01M
16.27%-5.76M
Investing cash flow
Cash flow from continuing investing activities
-21.63K
-282.37%-864.04K
-126.34%-266.76K
-8,352.90%-597.28K
0
0
-59.85%-225.97K
9.16%-117.86K
-73.91%-7.07K
-839.00%-70.98K
Net PPE purchase and sale
---21.63K
-282.37%-864.04K
-126.34%-266.76K
-8,352.90%-597.28K
--0
--0
-59.85%-225.97K
9.16%-117.86K
-73.91%-7.07K
-839.00%-70.98K
Cash from discontinued investing activities
Investing cash flow
---21.63K
-282.37%-864.04K
-126.34%-266.76K
-8,352.90%-597.28K
--0
--0
-59.85%-225.97K
9.16%-117.86K
-73.91%-7.07K
-839.00%-70.98K
Financing cash flow
Cash flow from continuing financing activities
1,461,648,800.00%43.85M
138.69%22.94M
-95.41%441K
22.5M
0
3
669.59%9.61M
961,065,600.00%9.61M
0
0
Net preferred stock issuance
----
130.47%22.15M
--0
----
----
----
--9.61M
--9.61M
----
----
Proceeds from stock option exercised by employees
1,461,648,800.00%43.85M
--789.64K
--441K
--348.64K
--0
--3
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
1,461,648,800.00%43.85M
138.69%22.94M
-95.41%441K
--22.5M
--0
--3
669.59%9.61M
961,065,600.00%9.61M
--0
--0
Net cash flow
Beginning cash position
-51.85%9.56M
-44.36%19.87M
6.75%18.99M
-79.23%5.15M
-58.60%12.68M
-44.36%19.87M
-37.54%35.7M
-55.92%17.79M
-46.97%24.81M
-42.88%30.63M
Current changes in cash
524.10%30.47M
34.96%-10.3M
-552.73%-9.42M
297.05%13.83M
-29.19%-7.53M
-41.69%-7.18M
26.20%-15.84M
144.84%2.08M
-9.13%-7.02M
14.90%-5.83M
End cash Position
215.64%40.03M
-51.85%9.56M
-51.85%9.56M
6.75%18.99M
-79.23%5.15M
-58.60%12.68M
-44.36%19.87M
-44.36%19.87M
-55.92%17.79M
-46.97%24.81M
Free cash flow
-86.30%-13.38M
-30.62%-33.24M
-30.98%-9.86M
-23.43%-8.67M
-29.19%-7.53M
-41.69%-7.18M
-12.06%-25.45M
-62.25%-7.53M
-9.13%-7.02M
15.33%-5.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -86.00%-13.36M-28.37%-32.38M-29.47%-9.6M-15.04%-8.07M-30.78%-7.53M-42.54%-7.18M-11.76%-25.22M-64.30%-7.41M-9.09%-7.01M16.27%-5.76M
Net income from continuing operations -151.50%-21.58M-32.80%-37.98M-3.24%-7.45M-75.80%-13.73M-10.57%-8.22M-39.76%-8.58M-18.57%-28.6M-21.92%-7.22M-34.24%-7.81M-23.34%-7.44M
Operating gains losses --9.9M-15,752.69%-530K---4.9M------------15.29%3.39K--0--0----
Depreciation and amortization 107.93%88.49K29.60%192.38K83.34%69.96K25.02%41.21K14.02%38.65K-1.98%42.56K-0.99%148.44K-2.88%38.16K-10.41%32.96K-12.42%33.9K
Other non cash items 11.62%15.44K-35.81%58.05K-36.01%15.28K-35.98%14.73K-35.94%14.21K-35.25%13.83K16.35%90.43K16.17%23.89K16.30%23.01K16.40%22.18K
Change In working capital -339.90%-2.24M106.43%3.48M355.30%1.58M97.82%740.65K-81.73%218.89K27.56%933.01K747.12%1.68M-163.97%-620.16K134.42%374.41K208.27%1.2M
-Change in prepaid assets 8.14%-448.96K-184.97%-173.55K-24.77%235.24K-34.36%-666.79K165.97%746.72K-556.47%-488.72K319.49%204.24K73.14%312.69K29.21%-496.27K-34.38%280.75K
-Change in payables and accrued expense -225.14%-1.78M127.91%3.7M253.51%1.36M57.27%1.42M-153.96%-512.87K117.13%1.43M294.33%1.62M-208.31%-888.59K353.77%904.77K163.16%950.55K
-Change in other current liabilities -5.96%-4.64K64.70%-50.85K63.78%-16.03K54.58%-15.48K55.03%-14.95K86.50%-4.38K-20.13%-144.04K-39.92%-44.26K-13.03%-34.09K-13.03%-33.25K
Cash from discontinued investing activities
Operating cash flow -86.00%-13.36M-28.37%-32.38M-29.47%-9.6M-15.04%-8.07M-30.78%-7.53M-42.54%-7.18M-11.76%-25.22M-64.30%-7.41M-9.09%-7.01M16.27%-5.76M
Investing cash flow
Cash flow from continuing investing activities -21.63K-282.37%-864.04K-126.34%-266.76K-8,352.90%-597.28K00-59.85%-225.97K9.16%-117.86K-73.91%-7.07K-839.00%-70.98K
Net PPE purchase and sale ---21.63K-282.37%-864.04K-126.34%-266.76K-8,352.90%-597.28K--0--0-59.85%-225.97K9.16%-117.86K-73.91%-7.07K-839.00%-70.98K
Cash from discontinued investing activities
Investing cash flow ---21.63K-282.37%-864.04K-126.34%-266.76K-8,352.90%-597.28K--0--0-59.85%-225.97K9.16%-117.86K-73.91%-7.07K-839.00%-70.98K
Financing cash flow
Cash flow from continuing financing activities 1,461,648,800.00%43.85M138.69%22.94M-95.41%441K22.5M03669.59%9.61M961,065,600.00%9.61M00
Net preferred stock issuance ----130.47%22.15M--0--------------9.61M--9.61M--------
Proceeds from stock option exercised by employees 1,461,648,800.00%43.85M--789.64K--441K--348.64K--0--3--0--0--0--0
Cash from discontinued financing activities
Financing cash flow 1,461,648,800.00%43.85M138.69%22.94M-95.41%441K--22.5M--0--3669.59%9.61M961,065,600.00%9.61M--0--0
Net cash flow
Beginning cash position -51.85%9.56M-44.36%19.87M6.75%18.99M-79.23%5.15M-58.60%12.68M-44.36%19.87M-37.54%35.7M-55.92%17.79M-46.97%24.81M-42.88%30.63M
Current changes in cash 524.10%30.47M34.96%-10.3M-552.73%-9.42M297.05%13.83M-29.19%-7.53M-41.69%-7.18M26.20%-15.84M144.84%2.08M-9.13%-7.02M14.90%-5.83M
End cash Position 215.64%40.03M-51.85%9.56M-51.85%9.56M6.75%18.99M-79.23%5.15M-58.60%12.68M-44.36%19.87M-44.36%19.87M-55.92%17.79M-46.97%24.81M
Free cash flow -86.30%-13.38M-30.62%-33.24M-30.98%-9.86M-23.43%-8.67M-29.19%-7.53M-41.69%-7.18M-12.06%-25.45M-62.25%-7.53M-9.13%-7.02M15.33%-5.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg